Southampton Joint Formulary Formulary


	Southampton Joint Formulary

Search

Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter

12.02.01

Drugs used in nasal allergy

Azelastine and fluticasone (Dymista)
(nasal spray)

Third Choice

Third line therapy for allergic rhinitis where response to treatment with other therapies, including combination of oral antihistamines and intranasal corticosteroids, was inadequate or not tolerated

12.02.01

Corticosteroids

Beclometasone Dipropionate
(Nasal spray)

First Choice

First line for adults in nasal allergy

Mometasone Furoate
(nasal spray)

First Choice

First line for children and for treatment of nasal polyps in adults

Second line to beclometasone propionate in adults for seasonal allergic or perennial rhinitis

Betamethasone eye/ear/nose drops

Formulary

Fluticasone furoate (Avamys^®)
(nasal spray)

Formulary

Second or third line for nasal allergy for patients who do not respond to beclometasone dipropionate, or who need a different device.

Fluticasone propionate (Flixonase Nasule Drops^®)
(nasal drops)

Formulary

For treatment of symptoms of severe chronic rhinosinusitis with nasal polyps as second line option if control with glucocorticoid nasal sprays is insufficient.

unlicensed in children under 16 years old.

....

Non Formulary Items

Budesonide (Rhinocort Aqua^®)

Non Formulary

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine

Traffic Light Status Information

Status	Description
	Suitable for prescribing by all in both primary and secondary care.
	Specialist recommended but suitable for continuation in primary care.
	Specialist initiated but suitable for continuation in primary care.
	Specialist initiated and for continuation in primary care under a locally approved shared care guideline.
	Suitable for prescribing in specialist settings (secondary care) only.
	Secondary care medicines to be used under specialised commissioning arrangements only.
	For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy.
	Not recommended for use.